What: Clinique La Prairie launches a €100 million Longevity Fund to invest in science-backed wellness startups, targeting technologies in medical, nutrition, wellness, and movement sectors.

Why it is important: The fund's launch signals a strategic shift in luxury wellness investment, capitalizing on the growing convergence of scientific validation and consumer wellness solutions at a time when traditional luxury markets face declining sales.

Clinique La Prairie's venture into investment marks a significant evolution in the luxury wellness sector with the launch of its €100 million Longevity Fund. Co-chaired by CEO Simone Gibertoni and former Nestlé chief technology officer Dr Stefan Catsicas, the fund aims to scale companies that bridge scientific innovation with longevity-focused solutions. Opening for applications in February 2025, the fund targets early-stage disruptors and series B candidates, with potential expansion to €300 million in subsequent closings. The initiative builds upon Clinique La Prairie's established presence in luxury wellness, including its high-profile retreats in Switzerland, China, and upcoming location in Saudi Arabia, which cater to executives and celebrities with programmes starting at CHF 26,900 weekly. The group's recent partnership with Beiersdorf, acquiring seven real estate assets, further strengthens its market position and creates synergies between cutting-edge treatments and wellness offerings. This strategic move reflects the industry's growing focus on scientifically validated wellness solutions and personalised health technologies.

IADS Notes: Clinique La Prairie's Longevity Fund emerges at a transformative moment in luxury wellness. As seen in January 2025, L'Oréal's introduction of Cell BioPrint technology demonstrates the market's appetite for scientifically-validated solutions. This trend aligns with Chanel's November 2024 launch of its dedicated Maison de Beauté, establishing new standards for personalized wellness services. The timing is particularly strategic given the luxury market's December 2024 data showing a 2% decline in global sales, suggesting wellness and longevity as promising growth avenues. The fund's focus on technology-driven solutions corresponds with the industry's shift toward biometric tracking and personalization, positioning it at the intersection of luxury, wellness, and technological innovation.

Longevity: The wellness world’s hottest investment